Masters Capital Management LLC Abb Vie Inc. Call Options Transaction History

Masters Capital Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $106 Million - $121 Million	-1,000,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $105 Million - $117 Million	1,000,000 New	1,000,000 $113 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $102 Million - $113 Million	-1,000,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $80.5 Million - $109 Million	1,000,000 New	1,000,000 $107 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $36.7 Million - $49.1 Million	-500,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $1.48 Million - $2.25 Million	23,000 Added 4.82%	500,000 $38.1 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $34.4 Million - $43 Million	477,000 New	477,000 $42.2 Million

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $306B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Masters Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Masters Capital Management LLC with notifications on news.